Prior to the COVID-19 pandemic, there were very few telemedicine clinics for HF. “Social distancing measures and increased demands on health services resulted in a shift to ‘remote by default’ clinic appointments in many organisations across Europe,” explained Dr Arvind Singhal (Royal Brompton Hospital, UK) [1]. Digital health, focusing on teleconsultation, remote monitoring, and apps and wearables, can be used to support HF care and improve outcomes [2].
Dr Singhal presented clinician experiences of telemedicine from 16 March 2020 to 15 March 2021 at the Royal Brompton Hospital. During this time, there were 2,725 HF clinic appointments, and 99% of them were by telemedicine. The investigators interviewed 8 clinicians: 4 HF consultants, 3 HF specialist nurses, and 1 training-grade doctor. In these interviews, 4 key themes emerged:
- time management,
- information gathering,
- rapport and relationships, and
- choice and flexibility.
“Teleconsultations resulted in a more focused assessment and less time between appointments,” Dr Singhal explained. Clinicians also felt less guilty to keep consultations brief as patients had not travelled to their appointments. On the other hand, this advantage was offset by the longer preparation time.
The second theme that emerged was information gathering. Without physical examinations, clinicians relied more on history and objective data such as test results or imaging. Video consultations were perceived as superior to telephone consultations for assessing patients due to the ability to pick up visual clues. “Examination of oedema was possible with video but more difficult and less reliable than in-person assessment,” Dr Singhal said.
Telemedicine also changed the relationship between clinicians and patients. Clinicians experienced difficulty establishing rapport with new patients by telephone. Video was better than telephone, but clinicians still felt the lack of human connection that one experiences when meeting people face-to-face. Regarding choice and flexibility, clinicians expressed fear of a ‘one-size-fits-all’ approach for future delivery of care.
Finally, all clinicians felt that telemedicine consultation will continue to play a major role as they are more convenient for patients but patient´s choice is essential. Taken together, telemedicine HF consultations were acceptable for healthcare providers, but changed the workflow, consultation dynamics, and how clinicians establish a relationship with the patient.
- Singhal A, et al. Clinician experiences of telemedicine heart failure clinics: The VIDEO-HF study. P61068, Heart Failure and World Congress on Acute Heart Failure 2021, 29 June–1 July.
- Singhal A, Cowie MR. Card Fail Rev 2021;7:e08.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« COVID-19-related HF: from systemic infection to cardiac inflammation Next Article
Echocardiographic parameters linked to dementia diagnosis »
« COVID-19-related HF: from systemic infection to cardiac inflammation Next Article
Echocardiographic parameters linked to dementia diagnosis »
Table of Contents: HFA 2021
Featured articles
Inconclusive results for dapagliflozin treatment in heart failure
Late-Breaking Trials
Iron substitution improves LVEF in intensively treated CRT patients with iron deficiency
Novel mineralocorticoid receptor antagonist effective irrespective of HF history
Iron substitution in iron-deficient HF patients is highly cost-effective
Omecamtiv mecarbil might be less effective in patients with atrial fibrillation or flutter
Vericiguat effective irrespective of atrial fibrillation status
Baroreflex activation: a novel option to improve heart failure symptoms
Beta-blocker withdrawal to enhance exercise capacity in heart failure?
Inconclusive results for dapagliflozin treatment in heart failure
Computerised cognitive training improves cognitive function in HF patients
COVID-19 and the Heart
COVID-19-related HF: from systemic infection to cardiac inflammation
Myocardial infarction outcomes were significantly affected by the pandemic
TAPSE effective biomarker associated with high-risk of severe COVID-19
COVID-19 in AF patients with HF: no higher mortality but longer hospital stay
Cancer and the Heart
Heart failure patients might be at an increased risk for head and neck cancer
Trastuzumab associated with cardiotoxicity in breast cancer
Heart Failure Prevention and HRQoL in the 21st century
Psychoactive substances put young people at risk of cardiovascular disease
The challenge of improving the quality of life of heart failure patients
SGLT2 Inhibitors in Heart Failure
Empagliflozin linked to lower cardiovascular risk and renal events in real-world study
Efficacy of dapagliflozin and empagliflozin not influenced by diabetes status
Biomarker panel predicts SGLT2 inhibitor response
Best of the Posters
Real-world study suggests sacubitril/valsartan benefits elderly patients with HF
Proenkephalin: A useful biomarker for new-onset heart failure?
Weight loss associated with increased mortality risk in heart failure patients
Echocardiographic parameters linked to dementia diagnosis
Related Articles
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com